Outcomes 2019 - Baylor Scott & White Heart and Vascular Hospital BSWHHVH_646_2019 Outcomes JOOMAG MOD | Page 24

Overall AMI composite
score
98.2%
INTERVENTIONAL
CARDIOLOGY
For STEMI patients on
11* acute and discharge
performance
measures
(FY19)
The Baylor Scott & White Heart and Vascular Hospital – Dallas interventional cardiology program
is supported by 11 well-equipped labs—four of which are heart and vascular capable, five labs are
EP capable, one is used for endovascular cases, and two serve as hybrid rooms. In addition, labs
are equipped with advanced technology, including digital subtraction, intravascular ultrasound,
intracardiac echocardiography and coronary flow wire—equipment that enhances data accuracy
and accessibility.
Robotic-assisted coronary angioplasty is an additional technology available to interventional cardiologists
on the hospital’s medical staff. Robotics improves the precision of stent and balloon placements and
reduces radiation exposure during the procedure for physicians. Cardiologists on the medical staffs at
both the Dallas and Fort Worth campuses became a part of a small group in the state of Texas to first
use robotic-assisted technology to perform coronary angioplasties or place cardiac stents.
*Overall AMI performance composite: Includes ASA at arrival, Eval LV function, Reperfusion, Time to PCI/Therapy, DC Meds: ASA, BB, ACEI/ARB, Statin, Smoking, Cardiac Rehab.
Overall defect free care: The proportion of patients that receive “perfect care” based upon their eligibility for each performance measure. Acute AMI performance composite: ASA at
arrival, Eval LV, Time to PCI/Therapy. Discharge AMI performance composite: DC BB, ACE/ARB, Statin, Smoking Cessation, Cardiac Rehab.